Patent · US Active

Modulators

US8926976B2 · kind B2 · utility

20Cited by
39References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2010
Grant dateJan 6, 2015
Priority date—
Expiry dateFeb 19, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that modulate insulin receptor signaling are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.